How Many Staff Should I Schedule Each Shift at My Urgent Care Clinic?
PULSEKNOWLEDGE LIBRARYQuality
Certified

Determine a fractional CRO's equity or profit-sharing structure by separating it into three layers: a base retainer that pays for guaranteed weekly capacity, a variable bonus tied to bookings or gross margin the CRO directly controls, and — only after 90-180 days of proven traction — a small equity or phantom-equity grant (typically 0.25%-1.5%, vested over 24-36 months). Never let equity replace cash comp for RevOps leadership carrying real quota risk.
The end-to-end process
Building a fractional CRO's compensation structure is a sequence, not a single negotiation. It starts before the contract is signed and continues through every quarterly review the engagement survives.
The first step is scoping the engagement honestly. A fractional CRO working two days a week on pipeline architecture and forecasting discipline is a different economic bet than one embedded four days a week running the sales team directly. Days-per-week and decision authority set the floor for the base retainer — most fractional CRO retainers for a 2-3 day/week engagement land between $8,000 and $18,000 a month in the current market, scaled by company revenue stage and the CRO's track record. That retainer is not negotiable against future upside; it is payment for calendar time and accountability, full stop.

Second comes the diagnostic phase, usually the first 30-45 days. The CRO audits the funnel, the CRM data quality, the comp plans already in place for the sales team, and the actual gross margin per deal type. This diagnostic matters for the equity conversation later because you cannot fairly size a profit-sharing structure against a baseline nobody has measured. A founder who offers 1% equity in month one, before anyone has agreed what "improvement" even means, is guessing. The diagnostic gives both sides a shared number: current win rate, current average deal cycle, current gross margin per segment.
Third is structuring the variable component, which should be negotiated only after the diagnostic produces a baseline. The healthiest models tie the bonus to metrics the CRO actually controls — net-new ARR closed under their direct oversight, or gross margin improvement on renegotiated contracts — rather than company-wide revenue, which a two-day-a-week operator cannot fully own. A common structure: 3%-8% of net-new ARR they personally influence above an agreed baseline, paid quarterly, capped so a single mega-deal doesn't blow the plan.
Fourth is the equity or profit-share layer, and this is where most founders and fractional operators talk past each other. Equity should never be the entry price of the engagement. It should be the reward for a CRO who has already proven the model works — typically offered as a top-up after the second or third quarter, once the diagnostic-stage baseline has moved in a measurable direction. Structure it as a standard advisor-grade grant: 0.25%-1% for a part-time strategic role, up to 1.5%-2% only if the CRO is functioning as a de facto co-founder with outsized influence over the go-to-market roadmap, vested monthly over 24-36 months with a 3-6 month cliff so a bad-fit engagement doesn't leave dead equity on the cap table.

Fifth is the review cadence. Every 90 days, both sides revisit the split: is the retainer still matched to the hours actually being spent, is the bonus formula still tied to metrics the CRO controls, has the company's stage changed enough (a Series A raise, a pivot in ICP) that the original structure no longer fits. Fractional engagements that never revisit the structure tend to either underpay the CRO once they've proven value, or overpay them once the company has scaled past the need for fractional help at all.
Where it creates or leaks revenue
The structure itself is a revenue lever, not just a cost line. Get the mix wrong and you either starve the CRO of upside — so they coast on the retainer and never push for the harder wins — or you hand out equity so loosely that it stops motivating anything by month twelve.

Revenue creation happens when the variable component is tied to margin, not just top-line bookings. A fractional CRO paid purely on closed-won ARR has every incentive to chase volume and discount hard to hit the number, which quietly erodes the gross margin the equity of the business actually depends on. Structures that split the bonus — say 60% on net-new ARR and 40% on gross margin retained or improved on renegotiated accounts — keep the CRO focused on deals the company can actually afford to win. This matters more in a fractional relationship than a full-time one, because the fractional CRO has less day-to-day visibility into delivery cost and support burden; a margin-linked bonus forces them to ask about it.
Revenue leaks in three predictable places. The first is scope creep without repricing: a fractional CRO hired for pipeline strategy gradually absorbs sales management, hiring, and even customer success escalations, but the retainer never moves. The company gets more labor for the same money short-term, but the CRO either quietly disengages or renegotiates aggressively later, and either way the relationship becomes adversarial. The fix is a quarterly scope-and-rate check built into the review cadence above.

The second leak is misaligned equity timing. Founders who offer equity upfront to make the retainer look cheaper are effectively financing current cash flow with future dilution — and if the engagement doesn't work out, that equity is nearly impossible to claw back cleanly without a properly drafted vesting and cliff schedule. RevOps advisors who've seen this pattern across dozens of fractional placements consistently flag early, uncapped equity as the single most common regret on the founder side.
The third leak is bonus formulas that don't decay. A bonus percentage that made sense when the company was doing $2M ARR can become an absurd payout at $20M ARR if nobody built in a step-down or a cap. Structure the variable component with a ceiling — a maximum dollar payout per quarter, or a declining percentage above certain ARR thresholds — so the incentive scales sensibly with the business instead of becoming a fixed tax on growth.

Concrete numbers and benchmarks
Anchor the negotiation in ranges, not a single number pulled from a blog post, because engagement scope varies too much for one figure to be fair everywhere.
Base retainer: $6,000-$10,000/month for one day a week, $10,000-$18,000/month for two to three days a week, $18,000-$30,000+/month for four days a week bordering on a part-time full executive role. Early-stage companies (pre-Series A, under $3M ARR) typically sit at the lower end; growth-stage companies ($10M+ ARR) with a fractional CRO overseeing a larger sales org sit at the upper end.
Variable bonus: 3%-8% of net-new ARR the CRO directly influenced, paid quarterly rather than annually so the incentive stays close to the behavior. Some structures instead use a flat bonus pool — 10%-20% of the gross margin improvement over the diagnostic-stage baseline — which works better when the CRO's mandate is efficiency and pricing discipline rather than pure new-logo growth.

Equity or phantom equity: 0.25%-0.5% for a light-touch, one-to-two-day advisory-style engagement; 0.5%-1% for a genuine two-to-three-day operating role with real authority over the funnel and comp plans; 1%-2% only when the fractional CRO is effectively acting as a founding go-to-market partner, often paired with a path to converting to a full-time executive role. Vesting: 24 months is the floor, 36 months is more common for anything above 0.5%, with a 3-6 month cliff standard across nearly all advisor and fractional-executive equity grants.
Total comp blend: as a sanity check, the annualized cash value of the retainer plus expected bonus for a two-to-three-day/week fractional CRO should land somewhere between $150,000 and $280,000 on a full-time-equivalent basis — meaningfully below what a full-time CRO commands ($220,000-$400,000+ base at a similar stage), which is the entire economic argument for going fractional in the first place. If the blended fractional cost approaches full-time CRO comp, the company has likely outgrown the fractional model.

Review cadence and caps: quarterly structure reviews, an annual hard cap on total bonus payout (commonly 1.5x-2x the annualized retainer) to prevent a single outsized deal from distorting the plan, and a formal step-down clause that reduces the bonus percentage once ARR crosses a pre-agreed threshold.
Pitfalls and how to avoid them
Offering equity before there's a baseline. Equity granted in the first meeting, before any diagnostic has established what "success" looks like, is a founder guessing at value they haven't measured yet. Avoid it by holding equity conversations until at least one full quarter of data exists.

Treating equity as a substitute for a fair retainer. A cash-strapped company sometimes tries to lowball the retainer and "make up for it" with a bigger equity number. Experienced fractional CROs recognize this pattern immediately and either decline or discount their effective involvement — equity they may never see fully vest doesn't pay rent. Keep the retainer at a real market rate and treat equity purely as upside, never as a substitute.
No clawback or cliff on equity. Without a 3-6 month cliff, a fractional CRO who disengages after six weeks walks away with vested equity for essentially no delivered value. Standard advisor equity documentation (a simple advisor agreement with a vesting schedule) closes this gap cheaply — it's a one-time legal cost, not an ongoing one.

Bonus tied to metrics the CRO doesn't control. Paying a fractional CRO on total company revenue when they only oversee one segment or one motion (say, outbound) creates resentment on both sides — the founder feels overpaying for results driven by other teams, and the CRO feels underpaid when their segment overperforms but company-wide numbers lag. Scope the bonus metric as tightly as the CRO's actual authority.
No sunset clause for the fractional-to-full-time transition. Many of the best fractional CRO engagements eventually convert to full-time as the company scales — but if the original agreement never addressed how existing equity or bonus structures transition, that negotiation becomes messy right when the company can least afford friction at the leadership level. Build a simple conversion clause into the original agreement: how unvested equity carries forward, how the retainer converts to a full-time base.
Structuring the deal like a full-time hire. Full-time CRO comp plans usually include long-term incentive equity sized as a career bet (often 1%-4%+ for an early full-time exec). Applying that same math to a two-day-a-week fractional engagement wildly overpays for the actual time and risk involved. Keep the fractional structure proportional to actual hours and actual decision authority, not a scaled-down copy of a full-time offer letter.

Selection checklist
Before finalizing the structure, run through this sequence with whoever is doing the hiring — usually the founder or CEO, sometimes alongside a fractional CFO or the board.
Walk every fractional CRO negotiation through that same order — retainer first, diagnostic second, bonus third, equity last — and the structure stays defensible even as the engagement scales or eventually converts to a full-time role.
Related questions
How is a fractional CRO different from a full-time CRO on comp?
A fractional CRO's comp is proportional to hours and scoped authority — a fraction of full-time cash comp with little to no upfront equity. Full-time CROs carry larger base salaries plus meaningful long-term equity as a career-length bet on the company.
Should a fractional CRO get commission like a sales rep?
No — commission structures assume full ownership of a deal from prospecting to close. A fractional CRO's bonus should track the metrics they actually influence, like pipeline quality or margin improvement, not individual rep-style commission on each closed deal.
When does a fractional CRO typically convert to full-time?
Most conversions happen once the company outgrows the two-to-three-day capacity — usually $8M-$15M ARR with a sales team large enough to need daily leadership. The original agreement should specify how unvested equity and bonus terms carry into the new role.
Can profit-sharing replace equity entirely for a fractional CRO?
Yes, and many engagements do exactly that, especially at companies not planning to raise venture funding. A profit-share tied to gross margin improvement avoids cap table dilution while still giving the CRO real upside tied to the business's actual health.
FAQ
What percentage of equity is normal for a fractional CRO? Most fractional CRO equity grants fall between 0.25% and 1.5%, scaled by hours committed and depth of authority. Grants above 1.5%-2% usually signal the role has effectively become a founding go-to-market partnership rather than a true fractional engagement.
Should the base retainer ever be reduced in exchange for more equity? Generally no. A retainer priced below market to "make room" for equity shifts real financial risk onto the CRO for a return they may never fully realize. Keep the retainer at a fair cash rate and treat equity as separate upside.
How often should the compensation structure be revisited? Quarterly is the standard cadence. It's frequent enough to catch scope creep or a bonus formula that's stopped fitting the company's stage, without renegotiating so often that it creates instability in the relationship.
Does profit-sharing work differently than a bookings-based bonus? Yes. A bookings-based bonus rewards closing deals regardless of their eventual profitability, while profit-sharing ties payout to gross margin retained or improved — which better protects the business from a CRO chasing volume at the expense of deal quality.
What happens to unvested equity if the engagement ends early? With a standard 3-6 month cliff and monthly vesting after that, unvested shares simply don't vest — they return to the option pool. This is why a written vesting schedule, not a verbal equity promise, is non-negotiable before any grant is made.
Is a phantom equity plan a reasonable substitute for real equity? Yes, particularly for companies that don't want additional names on the cap table or that operate without formal equity at all (like an LLC). Phantom equity mirrors the economic upside of real equity through a cash payout tied to a future sale or valuation event, without actual share issuance.
Sources
- https://hbr.org/2021/01/what-is-a-fractional-executive
- https://www.saastr.com/fractional-executives-what-they-really-cost/
- https://www.forbes.com/sites/forbesbusinesscouncil/
- https://carta.com/learn/equity/startup-equity/advisor-equity/
- https://www.investopedia.com/terms/p/profitsharingplan.asp
- https://www.shrm.org/topics-tools/news/compensation
- https://www.nceo.org/articles/vesting-cliffs
- https://www.gartner.com/en/sales/topics/chief-revenue-officer
Related on PULSE
- [Who places fractional Chief Revenue Officers?](/knowledge/tl21653)
- [What service finds fractional CROs for you?](/knowledge/tl21652)
- [Can I find a fractional CRO on LinkedIn?](/knowledge/tl21651)
- [Is there a directory of fractional CROs?](/knowledge/tl21650)
- [Who do I contact to find a fractional Chief Revenue Officer?](/knowledge/tl21649)
This page will be disappearing soon. Save it to your device for $1 — or read it free while it is here.
@Kory-White- · if Venmo asks, the last 4 of my number are 2012









